The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]

Johannes W G Jacobs*, Maarten Boers, John R. Kirwan, Johannes W J Bijlsma

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)2031-2032
Number of pages2
JournalArthritis and Rheumatism
Volume54
Issue number6
DOIs
Publication statusPublished - 1 Jun 2006

Cite this